World Health Organization press release
18 May 2026 | Geneva — The World Health Organization (WHO) has issued its first recommendation on the use of doxycycline post-exposure prophylaxis (PEP) – commonly referred to as doxyPEP – for the prevention of bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women.
The new recommendation, issued following a WHO guideline development process, reflects growing evidence that doxycycline taken after sexual exposure can reduce the risk of syphilis and chlamydia, and may also reduce gonorrhoea in some settings. These infections continue to rise in many regions worldwide, disproportionately affecting key populations.
Read the full press release here.
Access the recommendation here.
Source : World Health Organization
Related HIV and Co-Infections News
-
New JIAS viewpoint for International Day Against Homophobia, Biphobia and Transphobia
-
HIV i-Base: England’s HIV Action Plan: on target for HIV 2030 goals on preventable deaths but not for diagnoses: some key populations not included
-
HIV i-Base: New study predicts that PrEP efficacy in men is driven by drug levels in cells: matching earlier results in women
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.